Rezulin (REZ-u-lin, troglitazone), for Type II diabetes

January 1997

The FDA will soon approve Rezulin (REZ-u-lin, troglitazone), for Type II diabetes.

It has the potential to be a significant advance.

Troglitazone helps reduce insulin resistance...an underlying metabolic defect in most patients with Type II diabetes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Potent new lipid-lowering drug, Lipitor (atorvastatin)
Cardiology Several alternatives for patients who get a chronic cough from ACE inhibitors
Cardiology Beta blockers to reduce mortality and cardiovascular complications after noncardiac surgery
Asthma Leukotriene inhibitors for asthma
The new appetite suppressant, Redux (dexfenfluramine) for binge eating
Drugs that might prevent or delay Alzheimer's
Hypertension New COMBINATION antihypertensives
Diabetes Rezulin (REZ-u-lin, troglitazone), for Type II diabetes
Diabetes Computer software programs for diabetics
Thrombolytics Retavase (reteplase), a thrombolytic to restore blood flow after an acute MI
Antifungals Certain patients take Sporanox (itraconazole) or Nizoral (ketoconazole) tabs with a Coke or Pepsi
Antifungals Fungizone (amphotericin B) Oral Suspension
Antifungals Two LIPID formulations of IV amphotericin B ... Abelcet
Women's Health Common symptom of menopause is oral discomfort
Contraceptives New oral contraceptive, Estrostep
Contraceptives To determine if vaginal spermicides actually reduce the spread of STDs
Dermatology A new prescription antifungal cream
Practice Chart of significant new drugs approved in 1996